Low plasma tryptophan in carcinoid patients is associated with increased urinary cortisol excretion

Psychoneuroendocrinology

Volumn 33, Issue 9, 2008, Pages 1297-1301

  Tanke, Marit A C ^a,b   Kema, Ido P ^a   Dijck Brouwer, Janneke ^a   Doornbos, Bennard ^a,b   De Vries, Elisabeth G E ^a   Korf, Jakob ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Carcinoid tumor; Cortisol; HPA axis; Serotonin; Tryptophan

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; HYDROCORTISONE; INTERFERON; SEROTONIN; TRYPTOPHAN;

ADULT; AGED; ARTICLE; CARCINOID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDGUT; PRIORITY JOURNAL; URINARY EXCRETION;

BRAIN; CARCINOID TUMOR; GASTROINTESTINAL NEOPLASMS; HUMANS; HYDROCORTISONE; HYDROXYINDOLEACETIC ACID; NEOPLASM METASTASIS; NEOPLASM PROTEINS; RETROSPECTIVE STUDIES; SEROTONIN; TRYPTOPHAN;

EID: 51249097480     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2008.07.005     Document Type: Article

References (43)

1. Attia E., Wolk S., Cooper T., Glasofer D., and Walsh B.T. Plasma tryptophan during weight restoration in patients with anorexia nervosa. Biol. Psychiatry 57 (2005) 674-678
2. Bagdy G., Calogero A.E., Aulakh C.S., Szemeredi K., and Murphy D.L. Long-term cortisol treatment impairs behavioral and neuroendocrine responses to 5-HT1 agonists in the rat. Neuroendocrinology 50 (1989) 241-247
3. Capuron L., Ravaud A., Neveu P.J., Miller A.H., Maes M., and Dantzer R. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol. Psychiatry 7 (2002) 468-473
4. Chaouloff F. Serotonin, stress and corticoids. J. Psychopharmacol. 14 (2000) 139-151
5. D'Souza D.N., Zhang Y., Garcia F., Battaglia G., and Van de Kar L.D. Fluoxetine-induced changes in body weight and 5-HT1A receptor-mediated hormone secretion in rats on a tryptophan-deficient diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 (2004) R390-R397
6. Di Sciullo A., Bluet-Pajot M.T., Mounier F., Oliver C., Schmidt B., and Kordon C. Changes in anterior pituitary hormone levels after serotonin 1A receptor stimulation. Endocrinology 127 (1990) 567-572
7. Fadda F., Cocco S., and Stancampiano R. A physiological method to selectively decrease brain serotonin release. Brain Res. Protoc. 5 (2000) 219-222
8. Fuller R.W. Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats. Behav. Brain Res. 73 (1996) 215-219
9. Gerken A., Maier W., and Holsboer F. Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology. Psychoneuroendocrinology 10 (1985) 261-271
10. Goedert M., Otten U., Suda K., Heitz P.U., Stalder G.A., Obrecht J.P., Holzach P., and Allgower M. Dopamine, norepinephrine and serotonin production by an intestinal carcinoid tumor. Cancer 45 (1980) 104-107
11. Greden J.F., Gardner R., King D., Grunhaus L., Carroll B.J., and Kronfol Z. Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. Arch. Gen. Psychiatry 40 (1983) 493-500
12. Holdcroft A. Hormones and the gut. Br. J. Anaesth. 85 (2000) 58-68
13. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23 (2000) 477-501
14. Holsboer F., and Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr. Rev. 17 (1996) 187-205
15. Holsboer F., Liebl R., and Hofschuster E. Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement. J. Affect. Disord. 4 (1982) 93-101
16. Kema I.P., de Vries E.G., and Muskiet F.A. Clinical chemistry of serotonin and metabolites. J. Chromatogr. B: Biomed. Sci. Appl. 747 (2000) 33-48
17. Kema I.P., de Vries E.G., Schellings A.M., Postmus P.E., and Muskiet F.A. Improved diagnosis of carcinoid tumors by measurement of platelet serotonin. Clin. Chem. 38 (1992) 534-540
18. Kema I.P., de Vries E.G., Slooff M.J., Biesma B., and Muskiet F.A. Serotonin, catecholamines, histamine, and their metabolites in urine, platelets, and tumor tissue of patients with carcinoid tumors. Clin. Chem. 40 (1994) 86-95
19. Kema I.P., Meijer W.G., Meiborg G., Ooms B., Willemse P.H., and de Vries E.G. Profiling of tryptophan-related plasma indoles in patients with carcinoid tumors by automated, on-line, solid-phase extraction and HPLC with fluorescence detection. Clin. Chem. 47 (2001) 1811-1820
20. Koopmans S.J., Ruis M., Dekker R., van Diepen H., Korte M., and Mroz Z. Surplus dietary tryptophan reduces plasma cortisol and noradrenaline concentrations and enhances recovery after social stress in pigs. Physiol. Behav. 85 (2005) 469-478
21. Lucki I. The spectrum of behaviors influenced by serotonin. Biol. Psychiatry 44 (1998) 151-162
22. Meijer W.G., Kema I.P., Volmer M., Willemse P.H., and de Vries E.G. Discriminating capacity of indole markers in the diagnosis of carcinoid tumors. Clin. Chem. 46 (2000) 1588-1596
23. Moja E.A., Cipolla P., Castoldi D., and Tofanetti O. Dose-response decrease in plasma tryptophan and in brain tryptophan and serotonin after tryptophan-free amino-acid mixtures in rats. Life Sci. 44 (1989) 971-976
24. Mulder E.J., Oosterloo-Duinkerken A., Anderson G.M., de Vries E.G., Minderaa R.B., and Kema I.P. Automated on-line solid-phase extraction coupled with HPLC for measurement of 5-hydroxyindole-3-acetic acid in urine. Clin. Chem. 51 (2005) 1698-1703
25. Owens M.J., and Nemeroff C.B. The role of CRF in the pathophysiology of affective and anxiety disorders. In: Vale W., and Chichester (Eds). Corticotropin Releasing Factor CIBA Symposium (1993), Wiley pp. 296-319
26. Parker K.J., Schatzberg A.F., and Lyons D.M. Neuroendocrine aspects of hypercortisolism in major depression. Horm. Behav. 43 (2003) 60-66
27. Porter R.J., Gallagher P., and O'Brien J.T. Effects of rapid tryptophan depletion on salivary cortisol in older people recovered from depression, and the healthy elderly. J. Psychopharmacol. 21 (2007) 71-75
28. Porter R.J., Gallagher P., Watson S., and Young A.H. Corticosteroid-serotonin interactions in depression: a review of the human evidence. Psychopharmacology (Berl.) 173 (2004) 1-17
29. Porter R.J., Marshall E.F., and O'Brien J.T. Effects of rapid tryptophan depletion on salivary and plasma cortisol in Alzheimer's disease and the healthy elderly. J. Psychopharmacol. 16 (2002) 73-78
30. Ribeiro S.C., Tandon R., Grunhaus L., and Greden J.F. The DST as a predictor of outcome in depression: a meta-analysis. Am. J. Psychiatry 150 (1993) 1618-1629
31. Russo S., Boon J.C., Kema I.P., Willemse P.H., Den Boer J.A., Korf J., and de Vries E.G. Patients with carcinoid syndrome exhibit symptoms of aggressive impulse dysregulation. Psychosom. Med. 66 (2004) 422-425
32. Russo S., Kema I.P., Bosker F., Haavik J., and Korf J. Tryptophan as an evolutionarily conserved signal to brain serotonin: molecular evidence and psychiatric implications. World J. Biol. Psychiatry (2007) 1-11
33. Russo S., Kema I.P., Haagsma E.B., Boon J.C., Willemse P.H., Den Boer J.A., de Vries E.G., and Korf J. Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism. Psychosom. Med. 67 (2005) 773-777
34. Sachar E.J., Hellman L., Roffwarg H.P., Halpern F.S., Fukushima D.K., and Gallagher T.F. Disrupted 24-h patterns of cortisol secretion in psychotic depression. Arch. Gen. Psychiatry 28 (1973) 19-24
35. Sobczak S., Honig A., Nicolson N.A., and Riedel W.J. Effects of acute tryptophan depletion on mood and cortisol release in first-degree relatives of type I and type II bipolar patients and healthy matched controls. Neuropsychopharmacology 27 (2002) 834-842
36. Swain C.P., Tavill A.S., and Neale G. Studies of tryptophan and albumin metabolism in a patient with carcinoid syndrome, pellagra, and hypoproteinemia. Gastroenterology 71 (1976) 484-489
37. Tanke M.A., Alserda E., Doornbos B., van der Most P.J., Goeman K., Postema F., and Korf J. Low tryptophan diet increases stress-sensitivity, but does not affect habituation in rats. Neurochem. Int. 52 (2008) 272-281
38. Tuomisto J., and Mannisto P. Neurotransmitter regulation of anterior pituitary hormones. Pharmacol. Rev. 37 (1985) 249-332
39. Tyrka A.R., Carpenter L.L., McDougle C.J., Kirwin P.D., Owens M.J., Nemeroff C.B., Strong D.R., and Price L.H. Increased cerebrospinal fluid corticotropin-releasing factor concentrations during tryptophan depletion in healthy adults. Biol. Psychiatry 56 (2004) 531-534
40. Uyttenhove C., Pilotte L., Theate I., Stroobant V., Colau D., Parmentier N., Boon T., and Van den Eynde B.J. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat. Med. 9 (2003) 1269-1274
41. van der Horst-Schrivers A.N., Wymenga A.N., Links T.P., Willemse P.H., Kema I.P., and de Vries E.G. Complications of midgut carcinoid tumors and carcinoid syndrome. Neuroendocrinology 80 Suppl. 1 (2004) 28-32
42. Vielhaber K., Riemann D., Feige B., Kuelz A., Kirschbaum C., and Voderholzer U. Impact of experimentally induced serotonin deficiency by tryptophan depletion on saliva cortisol concentrations. Pharmacopsychiatry 38 (2005) 87-94
43. Zobel A.W., Yassouridis A., Frieboes R.M., and Holsboer F. Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. Am. J. Psychiatry 156 (1999) 949-951